{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:43:16Z","timestamp":1790692996216,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1097\/pat.0b013e3283426eee","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T07:22:59Z","timestamp":1298532179000},"page":"93-102","source":"Crossref","is-referenced-by-count":10,"title":["Overview and recent advances in neuropathology. Part 2: Neurodegeneration"],"prefix":"10.1016","volume":"43","author":[{"given":"Colin L.","family":"Masters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian J.","family":"Kril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Pamphlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/PAT.0b013e3283426eee_bib0005","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0010","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"An iron-export ferroxidase activity of b-amyloid protien precursor is inhibited by zinc in Alzheimer\u2019s Disease","volume":"142","author":"Duce","year":"2010","journal-title":"Cell"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0020","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer\u2019s disease: a phase Ila, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-b load in patients with Alzheimer\u2019s disease treated with bapineuzumab: a phase 2, double-blind, placebo controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-b toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0035","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","article-title":"Ab oligomers cause localized Ca2+ elevation, missorting of endogenous tau into dendrites, tau phos-phorylation, and destruction of microtubules and spines","volume":"30","author":"Zempel","year":"2010","journal-title":"J Neurosci"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0040","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1017\/S1041610209009405","article-title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer\u2019s disease","volume":"21","author":"Ellis","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.0b013e3181c918b5","article-title":"b-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in subjects without dementia","volume":"74","author":"Bourgeat","year":"2010","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0050","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1523\/JNEUROSCI.5180-09.2010","article-title":"Blood-borne amyloid-b dimer correlates with clinical markers of Alzheimer\u2019s disease","volume":"30","author":"Villemagne","year":"2010","journal-title":"J Neurosci"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0055","series-title":"Ann Neurol","article-title":"Longitudinal assesment of Ab and cognition in aging and Alzheimer\u2019s disease","author":"Villemagne","year":"2010"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0060","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-2010-090249","article-title":"Plasma amyloid-b as a biomarker in Alzheimer\u2019s disease: the AIBL study of aging","volume":"20","author":"Lui","year":"2010","journal-title":"JAlzheimers Dis"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and \u03b2-amyloid deposition in Alzheimer disease","volume":"67","author":"Chetelat","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0070","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","article-title":"Clinical and pathological diagnosis of frontotemporal dementia","volume":"58","author":"McKhann","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/brain\/awp248","article-title":"Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases","volume":"133","author":"Hodges","year":"2010","journal-title":"Brain"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000100973","article-title":"Clinical significance of lobar atrophy in frontotemporal dementia: applica-tion of an MRI visual rating scale","volume":"23","author":"Kipps","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00401-008-0460-5","article-title":"Nomenclature for neuro-pathologic subtypes of frontotemporal lobar degeneration: consensus re-commendations","volume":"117","author":"Mackenzie","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0095","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/01.WNL.0000052685.09194.39","article-title":"Staging disease severity in pathologically confirmed cases of frontotem-poral dementia","volume":"60","author":"Broe","year":"2003","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/brain\/awg085","article-title":"Severity of gliosis in Pick\u2019s disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders","volume":"126","author":"Schofield","year":"2003","journal-title":"Brain"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/mds.20286","article-title":"Staging disease severity in movement disorder tauopathies: Brain atrophy separates pro-gressive supranuclear palsy from corticobasal degeneration","volume":"20","author":"Schofield","year":"2005","journal-title":"Mov Disord"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000077161","article-title":"Clinicopathological staging of FTD severity: corre-lation with regional atrophy","volume":"17","author":"Kril","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2005.02.003","article-title":"Distribution of brain atrophy in behavioural variant frontotemporal dementia","volume":"232","author":"Kril","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00401-004-0917-0","article-title":"Regional and cellular pathology in frontotemporal dementia: Relationship to stage of disease in cases with and without Pick bodies","volume":"108","author":"Kersaitis","year":"2004","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2990.2005.00704.x","article-title":"Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neuron disease identifies a group with mainly early pathology","volume":"32","author":"Kersaitis","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.20203","article-title":"Clinicopathological correlates in frontotemporal dementia","volume":"56","author":"Hodges","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","article-title":"Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP","volume":"66","author":"Josephs","year":"2006","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-4-7","article-title":"Progranulin in frontotemporal lobar degeneration and neuroinflammation","volume":"4","author":"Ahmed","year":"2007","journal-title":"J Neuroinflam"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00401-009-0571-7","article-title":"TARDBP 30-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 pro- teinopathy","volume":"118","author":"Gitcho","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0150","first-page":"50","article-title":"Zur pathologischen anatomie der Paralysis Agitans","volume":"50","author":"Lewy","year":"1913","journal-title":"Dtsh Z Nervenheilk"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0155","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"a-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molmed.2005.01.001","article-title":"Gene dosage and pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Eriksen","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0165","first-page":"1150","article-title":"Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"LancetNeurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0170","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurol-ogy"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainresbull.2009.06.018","article-title":"Neuropathology of Lewy body disorders","volume":"80","author":"Kovari","year":"2009","journal-title":"Brain Res Bull"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0185","first-page":"409","article-title":"The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuro- pathol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0190","first-page":"741","article-title":"Research in motion: the enigma ofParkinson\u2019s disease pathology spread","volume":"9","author":"Brundin","year":"2008","journal-title":"NatRevNeurosci"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0195","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","article-title":"Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies","volume":"60","author":"Merdes","year":"2003","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0200","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","article-title":"In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution","volume":"69","author":"Weisman","year":"2007","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1533317507310565","article-title":"Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies","volume":"23","author":"Revuelta","year":"2008","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0210","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1750-3639.2007.00117.x","article-title":"Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient","volume":"18","author":"Leverenz","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1750-3639.2008.00244.x","article-title":"Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons","volume":"20","author":"Nelson","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0220","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: accel-eration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J Neurosci"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0225","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","article-title":"Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort","volume":"70","author":"Zaccai","year":"2008","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0230","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/17482960802635397","article-title":"A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis","volume":"10","author":"Morahan","year":"2009","journal-title":"Amyotroph Lateral Scier"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0235","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.mehy.2003.11.023","article-title":"Somatic mutation: a cause of sporadic neurodegenerative diseases?","volume":"62","author":"Pamphlett","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0240","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-007-0206-9","article-title":"TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation","volume":"113","author":"Tan","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0250","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.21425","article-title":"Phosphorylated TDP-43 in fronto-temporal lobar degeneration and amyotrophic lateral sclerosis","volume":"64","author":"Hasegawa","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0255","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/mus.880180308","article-title":"Motor neuron disease: a primary disorder of corticomotoneurons?","volume":"18","author":"Pamphlett","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0260","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2990.2008.00982.x","article-title":"TDP-43 neuropathology is similar in sporadic amyotrophic lateral sclerosis with or without TDP-43 mutations","volume":"35","author":"Pamphlett","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-008-0392-0","article-title":"TDP-43 inclusions do not protect motor neurons from sporadic ALS","volume":"116","author":"Pamphlett","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0270","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.0b013e3181e03b59","article-title":"Study of 962 patients indicates progressive muscular atrophy is a form of ALS","volume":"74","author":"Pamphlett","year":"2010","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0275","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2990.1993.tb00443.x","article-title":"Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease","volume":"19","author":"Ince","year":"1993","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mus.20755","article-title":"Frequent atrophic groups with mixed-type myofibers is distinctive to motor neuron syndromes","volume":"36","author":"Baloh","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)15171-9","article-title":"Transmissible spongiform encepha-lopathies","volume":"363","author":"Collins","year":"2004","journal-title":"Lancet"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0295","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.1100195","article-title":"Synthetic mammalian prions","volume":"305","author":"Legname","year":"2004","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0300","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cell.2005.02.011","article-title":"In vitro generation of infectious scrapie prions","volume":"121","author":"Castilla","year":"2005","journal-title":"Cell"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0305","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.1183748","article-title":"Generating a prion with bacterially expressed recombinant prion protein","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0310","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1212\/01.WNL.0000031793.11602.8C","article-title":"Creutzfeldt-Jakob disease in Australia 1970-1999","volume":"59","author":"Collins","year":"2002","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0315","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004390050204","article-title":"Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom - a systematic analysis of predisposing mutations and allelic variation in the PRNP gene","volume":"98","author":"Windl","year":"1996","journal-title":"Hum Genet"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0325","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kovacs","year":"2005","journal-title":"Hum Genet"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0330","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2010.01.043","article-title":"No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob disease","volume":"472","author":"Collins","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0335","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0340","doi-asserted-by":"crossref","first-page":"12005","DOI":"10.1073\/pnas.1004688107","article-title":"Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties","volume":"107","author":"Bishop","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0345","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/brain\/awp196","article-title":"Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics","volume":"132","author":"Cali","year":"2009","journal-title":"Brain"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0350","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","article-title":"Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutz-feldt-Jakob disease","volume":"129","author":"Collins","year":"2006","journal-title":"Brain"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0355","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ana.21420","article-title":"A novel human disease with abnormal prion protein sensitive to protease","volume":"63","author":"Gambetti","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0360","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1054\/jocn.2001.0919","article-title":"Gerstmann-Str\u00e4ussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies","volume":"8","author":"Collins","year":"2001","journal-title":"J Clin Neurosci"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0365","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199202133260704","article-title":"Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene","volume":"326","author":"Medori","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0370","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","article-title":"Iatrogenic Creutzfeldt-Jakob disease at the millennium","volume":"55","author":"Brown","year":"2000","journal-title":"Neurology"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0375","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","article-title":"Kuru in the 21st century\u2014an acquired human prion disease with very long incubation periods","volume":"367","author":"Collinge","year":"2006","journal-title":"Lancet"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0380","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0385","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(98)12075-5","article-title":"Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples","volume":"353","author":"Hill","year":"1999","journal-title":"Lancet"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0390","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0395","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/bmj.38804.511644.55","article-title":"Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study","volume":"332","author":"Ironside","year":"2006","journal-title":"BMJ"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0400","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14-3-3 brain protein in cere-brospinal fluid as a marker for transmissible spongiform encephalopathies","volume":"335","author":"Hsich","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0405","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0410","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nmeth0308-211","article-title":"Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking","volume":"5","author":"Atarashi","year":"2008","journal-title":"Nat Methods"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0415","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2990.2003.00544.x","article-title":"Advances in the detection of prion protien in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting","volume":"30","author":"Ritchie","year":"2004","journal-title":"Neruopathol Appl Neurobiol"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0420","first-page":"366","article-title":"Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients?","volume":"193","author":"Boyd","year":"2010","journal-title":"MJA"},{"key":"10.1097\/PAT.0b013e3283426eee_bib0425","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-006-0138-9","article-title":"Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype","volume":"112","author":"Mackenzie","year":"2006","journal-title":"Acta Neuropathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516330422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516330422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T13:35:33Z","timestamp":1712237733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516330422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0031302516330422"],"URL":"https:\/\/doi.org\/10.1097\/pat.0b013e3283426eee","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}